| Part Of FDA Advisory Committee Unanimously Approves Johnson & Johnson COVID-19 Vaccine

FDA Open Meeting on Johnson & Johnson COVID-19 Vaccine, Part 5

The Food and Drug Administration (FDA) held a virtual open meeting to discuss emergency use authorization for the Johnson & Johnson… read more

The Food and Drug Administration (FDA) held a virtual open meeting to discuss emergency use authorization for the Johnson & Johnson COVID-19 vaccine. The advisory board asked questions of the FDA and Janssen Biotech, which is the pharmaceutical division of Johnson & Johnson. Discussed were the efficacy of the vaccine, the importance of delivering a one-dose versus a two-dose vaccine, side effects experienced by study participants, and possible complications related to unmasking trial participants. This was the fifth and final portion of the daylong advisory board hearing. close

Report Video Issue

Points of Interest

For quick viewing, C-SPAN provides Points of Interest markers for some events.

Click the play button and tap the screen to see the at the bottom of the player. Tap the to see a complete list of all Points of Interest - click on any moment in the list and the video will play.

Points of Interest

For quick viewing, C-SPAN provides Points of Interest markers for some events.

Click the play button and move your cursor over the video to see the . Click on the marker to see the description and watch.

You can also click the in the lower left of the video player to see a complete list of all Points of Interest from this program - click on any moment in the list and the video will play.

People in this video

  • Prabhakara Atreya Director U.S. Food and Drug Administration->Scientific Advisers and Consultants
  • Archana Chatterjee Senior Associate Dean University of South Dakota->Medical School
  • Macaya Douoguih M.D. Head Johnson & Johnson->Vaccines Clinical Development
  • Oveta Fuller Professor University of Michigan Medical School
  • Hayley Gans Professor Stanford University->Pediatric Infectious Diseases
  • Marion Gruber Director U.S. Food and Drug Administration->Office of Vaccine Research and Review
  • Kathleen Hayes Designated Federal Officer U.S. Food and Drug Administration
  • Yosefa Hefter Pediatrician Children's National Health System
  • James Hildreth M.D. President and CEO Meharry Medical College
  • Mike Kaczynski Project Manager U.S. Food and Drug Administration
  • David Kim Director Centers for Disease Control and Prevention->Immunization Division
  • Michael Kurilla Director National Institutes of Health->Division of Clinical Innovation
  • Jeannette Lee Professor University of Arkansas->Biostatistics
  • Ofer Levy Director Boston Children's Hospital->Precision Vaccines Program
  • Wayne Marasco Doctor Dana-Farber Cancer Institute->Department of Cancer Immunology
  • Peter W. Marks M.D. Deputy Director U.S. Food and Drug Administration->Center for Biologics Evaluation and Research
  • Pamela McInnes Director National Institutes of Health->National Center for Advancing Translational Sciences
  • Cody Meissner Professor Tufts University->Infectious Diseases
  • Arnold Monto Professor University of Michigan->Epidemiology
  • Patrick Moore Professor University of Pittsburgh->Cancer Institute
  • Paul Offit M.D. Chief Children's Hospital of Philadelphia->Division of Infectious Diseases
  • Steven Pergam Professor Fred Hutchinson Cancer Research Center
  • Stanley Perlman M.D. Professor University of Iowa->Immunology
  • Gregory Poland M.D. Director Mayo Clinic->Vaccine Research Group
  • Jay Portnoy Professor Children's Mercy Hospital->Pediatrics
  • Eric Rubin Editor in Chief New England Journal of Medicine
  • Mark Sawyer M.D. Specialist Rady Children's Hospital->Infectious Diseases
  • Hanneke Schuitemaker Global Head Johnson & Johnson->Viral Vaccine Discovery
  • Johan Van Hoof M.D. Head Janssen Research and Development->Global Therapeutic Area
  • Melinda Wharton Director Centers for Disease Control and Prevention->Immunization Division
  • Roland Zahn Senior Scientific Director Janssen Pharmaceuticals->Viral Vaccines
  • Rachel Zhang Medical Officer U.S. Food and Drug Administration
More People

Hosting Organization

More Videos From

FDA Advisory Committee Unanimously Approves Johnson & Johnson COVID-19 Vaccine

More Videos
More information about

FDA Open Meeting on Johnson & Johnson COVID-19 Vaccine, Part 5

125 Views
Program ID:
509043-6
Category:
Public Affairs Event
Format:
Meeting
Location:
Washington, District of Columbia, United States
First Aired:
Feb 26, 2021 | 3:07pm EST | C-SPAN 2
Last Aired:
Feb 27, 2021 | 2:20am EST | C-SPAN 2

Airing Details

  • Feb 26, 2021 | 3:07pm EST | C-SPAN 2
  • Feb 26, 2021 | 3:16pm EST | C-SPAN 2
  • Feb 27, 2021 | 2:20am EST | C-SPAN 2